# Home OCT Fluid Visualization Agreement Study

> **NCT04907409** · — · UNKNOWN · sponsor: **Notal Vision Inc.** · enrollment: 120 (estimated)

## Conditions studied

- Neovascular Age-related Macular Degeneration

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04907409
- **Lead sponsor:** Notal Vision Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-17
- **Primary completion:** 2022-07-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04907409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04907409, "Home OCT Fluid Visualization Agreement Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04907409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*